Physician Wealth Advisors’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PTCT
RI
JT
Physician Wealth Advisors's PTCT Position: Q2 2026 in Review
Physician Wealth Advisors increased its PTC Therapeutics (PTCT) stake by 111% in Q2 2026, buying an estimated $722 and bringing the position to 19 shares worth $1.55K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.
Physician Wealth Advisors first reported a position in PTCT in Q2 2025 and has held it in 4 quarters since. 383 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Physician Wealth Advisors held 19 shares of PTC Therapeutics worth $1.55K as of Q2 2026.
- Physician Wealth Advisors bought 10 PTC Therapeutics shares in Q2 2026, an estimated $722.
- PTC Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1617 holding.
- Physician Wealth Advisors first reported a position in PTC Therapeutics in Q2 2025 and has held it in 4 quarters since.
- 383 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.